Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytes
Identifieur interne : 001345 ( Main/Exploration ); précédent : 001344; suivant : 001346Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytes
Auteurs : Hao Wang ; Chi Ma ; Yanlai Lu ; Xu Ji ; Yongsheng Pang ; Fang Hua ; Lianxian Cui ; Denian Ba ; Wei HeSource :
- Cellular and Molecular Immunology [ 1672-7681 ] ; 2013.
Descripteurs français
- KwdFr :
- Anticorps antiviraux (biosynthèse), Anticorps antiviraux (isolement et purification), Anticorps antiviraux (sang), Anticorps monoclonaux (biosynthèse), Anticorps monoclonaux (isolement et purification), Anticorps monoclonaux (sang), Anticorps neutralisants (biosynthèse), Anticorps neutralisants (isolement et purification), Anticorps neutralisants (sang), Chine (épidémiologie), Grippe humaine (), Grippe humaine (immunologie), Grippe humaine (sang), Grippe humaine (épidémiologie), Herpèsvirus humain de type 4 (génétique), Herpèsvirus humain de type 4 (immunologie), Humains, Lymphocytes B (immunologie), Lymphocytes B (métabolisme), Lymphocytes B (virologie), Mémoire immunologique, Pandémies, Sous-type H1N1 du virus de la grippe A (immunologie), Tests d'inhibition de l'hémagglutination, Tests de criblage à haut débit, Tests de neutralisation, Vaccination, Vaccins antigrippaux (administration et posologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- biosynthèse : Anticorps antiviraux, Anticorps monoclonaux, Anticorps neutralisants.
- génétique : Herpèsvirus humain de type 4.
- immunologie : Grippe humaine, Herpèsvirus humain de type 4, Lymphocytes B, Sous-type H1N1 du virus de la grippe A.
- isolement et purification : Anticorps antiviraux, Anticorps monoclonaux, Anticorps neutralisants.
- métabolisme : Lymphocytes B.
- sang : Anticorps antiviraux, Anticorps monoclonaux, Anticorps neutralisants, Grippe humaine.
- virologie : Lymphocytes B.
- épidémiologie : Chine, Grippe humaine.
- Grippe humaine, Humains, Mémoire immunologique, Pandémies, Tests d'inhibition de l'hémagglutination, Tests de criblage à haut débit, Tests de neutralisation, Vaccination.
- Wicri :
- geographic : République populaire de Chine.
English descriptors
- KwdEn :
- Antibodies, Monoclonal (biosynthesis), Antibodies, Monoclonal (blood), Antibodies, Monoclonal (isolation & purification), Antibodies, Neutralizing (biosynthesis), Antibodies, Neutralizing (blood), Antibodies, Neutralizing (isolation & purification), Antibodies, Viral (biosynthesis), Antibodies, Viral (blood), Antibodies, Viral (isolation & purification), B-Lymphocytes (immunology), B-Lymphocytes (metabolism), B-Lymphocytes (virology), China (epidemiology), Hemagglutination Inhibition Tests, Herpesvirus 4, Human (genetics), Herpesvirus 4, Human (immunology), High-Throughput Screening Assays, Humans, Immunologic Memory, Influenza A Virus, H1N1 Subtype (immunology), Influenza Vaccines (administration & dosage), Influenza, Human (blood), Influenza, Human (epidemiology), Influenza, Human (immunology), Influenza, Human (prevention & control), Neutralization Tests, Pandemics, Vaccination.
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- chemical , biosynthesis : Antibodies, Monoclonal, Antibodies, Neutralizing, Antibodies, Viral.
- chemical , blood : Antibodies, Monoclonal, Antibodies, Neutralizing, Antibodies, Viral.
- chemical , isolation & purification : Antibodies, Monoclonal, Antibodies, Neutralizing, Antibodies, Viral.
- geographic , epidemiology : China.
- blood : Influenza, Human.
- epidemiology : Influenza, Human.
- genetics : Herpesvirus 4, Human.
- immunology : B-Lymphocytes, Herpesvirus 4, Human, Influenza A Virus, H1N1 Subtype, Influenza, Human.
- metabolism : B-Lymphocytes.
- prevention & control : Influenza, Human.
- virology : B-Lymphocytes.
- Hemagglutination Inhibition Tests, High-Throughput Screening Assays, Humans, Immunologic Memory, Neutralization Tests, Pandemics, Vaccination.
Abstract
The 2009 H1N1 influenza pandemic demonstrated the significance of a global health threat to human beings. Although pandemic H1N1 vaccines have been rapidly developed, passive serotherapy may offer superior immediate protection against infections in children, the elderly and immune-compromised patients during an influenza pandemic. Here, we applied a novel strategy based on Epstein–Barr virus (EBV)-immortalized peripheral blood memory B cells to screen high viral neutralizing monoclonal antibodies (MAbs) from individuals vaccinated with the 2009 pandemic H1N1 vaccine PANFLU.1. Through a massive screen of 13 090 immortalized memory B-cell clones from three selected vaccinees, seven MAbs were identified with both high viral neutralizing capacities and hemagglutination inhibition (HAI) activities against the 2009 pandemic H1N1 viruses. These MAbs may have important clinical implications for passive serotherapy treatments of infected patients with severe respiratory syndrome, especially children, the elderly and immunodeficient individuals. Our successful strategy for generating high-affinity MAbs from EBV-immortalized peripheral blood memory B cells may also be applicable to other infectious or autoimmune diseases.
Url:
DOI: 10.1038/cmi.2013.25
PubMed: 23912783
PubMed Central: 4003197
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000001
- to stream Pmc, to step Curation: 000001
- to stream Pmc, to step Checkpoint: 000600
- to stream PubMed, to step Corpus: 000974
- to stream PubMed, to step Curation: 000974
- to stream PubMed, to step Checkpoint: 000A15
- to stream Ncbi, to step Merge: 001704
- to stream Ncbi, to step Curation: 001704
- to stream Ncbi, to step Checkpoint: 001704
- to stream Main, to step Merge: 001363
- to stream Main, to step Curation: 001345
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytes</title>
<author><name sortKey="Wang, Hao" sort="Wang, Hao" uniqKey="Wang H" first="Hao" last="Wang">Hao Wang</name>
</author>
<author><name sortKey="Ma, Chi" sort="Ma, Chi" uniqKey="Ma C" first="Chi" last="Ma">Chi Ma</name>
</author>
<author><name sortKey="Lu, Yanlai" sort="Lu, Yanlai" uniqKey="Lu Y" first="Yanlai" last="Lu">Yanlai Lu</name>
</author>
<author><name sortKey="Ji, Xu" sort="Ji, Xu" uniqKey="Ji X" first="Xu" last="Ji">Xu Ji</name>
</author>
<author><name sortKey="Pang, Yongsheng" sort="Pang, Yongsheng" uniqKey="Pang Y" first="Yongsheng" last="Pang">Yongsheng Pang</name>
</author>
<author><name sortKey="Hua, Fang" sort="Hua, Fang" uniqKey="Hua F" first="Fang" last="Hua">Fang Hua</name>
</author>
<author><name sortKey="Cui, Lianxian" sort="Cui, Lianxian" uniqKey="Cui L" first="Lianxian" last="Cui">Lianxian Cui</name>
</author>
<author><name sortKey="Ba, Denian" sort="Ba, Denian" uniqKey="Ba D" first="Denian" last="Ba">Denian Ba</name>
</author>
<author><name sortKey="He, Wei" sort="He, Wei" uniqKey="He W" first="Wei" last="He">Wei He</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23912783</idno>
<idno type="pmc">4003197</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003197</idno>
<idno type="RBID">PMC:4003197</idno>
<idno type="doi">10.1038/cmi.2013.25</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">000001</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000001</idno>
<idno type="wicri:Area/Pmc/Curation">000001</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000001</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000600</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000600</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:23912783</idno>
<idno type="wicri:Area/PubMed/Corpus">000974</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000974</idno>
<idno type="wicri:Area/PubMed/Curation">000974</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000974</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000A15</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A15</idno>
<idno type="wicri:Area/Ncbi/Merge">001704</idno>
<idno type="wicri:Area/Ncbi/Curation">001704</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001704</idno>
<idno type="wicri:doubleKey">1672-7681:2013:Wang H:generation:of:human</idno>
<idno type="wicri:Area/Main/Merge">001363</idno>
<idno type="wicri:Area/Main/Curation">001345</idno>
<idno type="wicri:Area/Main/Exploration">001345</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytes</title>
<author><name sortKey="Wang, Hao" sort="Wang, Hao" uniqKey="Wang H" first="Hao" last="Wang">Hao Wang</name>
</author>
<author><name sortKey="Ma, Chi" sort="Ma, Chi" uniqKey="Ma C" first="Chi" last="Ma">Chi Ma</name>
</author>
<author><name sortKey="Lu, Yanlai" sort="Lu, Yanlai" uniqKey="Lu Y" first="Yanlai" last="Lu">Yanlai Lu</name>
</author>
<author><name sortKey="Ji, Xu" sort="Ji, Xu" uniqKey="Ji X" first="Xu" last="Ji">Xu Ji</name>
</author>
<author><name sortKey="Pang, Yongsheng" sort="Pang, Yongsheng" uniqKey="Pang Y" first="Yongsheng" last="Pang">Yongsheng Pang</name>
</author>
<author><name sortKey="Hua, Fang" sort="Hua, Fang" uniqKey="Hua F" first="Fang" last="Hua">Fang Hua</name>
</author>
<author><name sortKey="Cui, Lianxian" sort="Cui, Lianxian" uniqKey="Cui L" first="Lianxian" last="Cui">Lianxian Cui</name>
</author>
<author><name sortKey="Ba, Denian" sort="Ba, Denian" uniqKey="Ba D" first="Denian" last="Ba">Denian Ba</name>
</author>
<author><name sortKey="He, Wei" sort="He, Wei" uniqKey="He W" first="Wei" last="He">Wei He</name>
</author>
</analytic>
<series><title level="j">Cellular and Molecular Immunology</title>
<idno type="ISSN">1672-7681</idno>
<idno type="eISSN">2042-0226</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Monoclonal (biosynthesis)</term>
<term>Antibodies, Monoclonal (blood)</term>
<term>Antibodies, Monoclonal (isolation & purification)</term>
<term>Antibodies, Neutralizing (biosynthesis)</term>
<term>Antibodies, Neutralizing (blood)</term>
<term>Antibodies, Neutralizing (isolation & purification)</term>
<term>Antibodies, Viral (biosynthesis)</term>
<term>Antibodies, Viral (blood)</term>
<term>Antibodies, Viral (isolation & purification)</term>
<term>B-Lymphocytes (immunology)</term>
<term>B-Lymphocytes (metabolism)</term>
<term>B-Lymphocytes (virology)</term>
<term>China (epidemiology)</term>
<term>Hemagglutination Inhibition Tests</term>
<term>Herpesvirus 4, Human (genetics)</term>
<term>Herpesvirus 4, Human (immunology)</term>
<term>High-Throughput Screening Assays</term>
<term>Humans</term>
<term>Immunologic Memory</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza, Human (blood)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (immunology)</term>
<term>Influenza, Human (prevention & control)</term>
<term>Neutralization Tests</term>
<term>Pandemics</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps antiviraux (biosynthèse)</term>
<term>Anticorps antiviraux (isolement et purification)</term>
<term>Anticorps antiviraux (sang)</term>
<term>Anticorps monoclonaux (biosynthèse)</term>
<term>Anticorps monoclonaux (isolement et purification)</term>
<term>Anticorps monoclonaux (sang)</term>
<term>Anticorps neutralisants (biosynthèse)</term>
<term>Anticorps neutralisants (isolement et purification)</term>
<term>Anticorps neutralisants (sang)</term>
<term>Chine (épidémiologie)</term>
<term>Grippe humaine ()</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (sang)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Herpèsvirus humain de type 4 (génétique)</term>
<term>Herpèsvirus humain de type 4 (immunologie)</term>
<term>Humains</term>
<term>Lymphocytes B (immunologie)</term>
<term>Lymphocytes B (métabolisme)</term>
<term>Lymphocytes B (virologie)</term>
<term>Mémoire immunologique</term>
<term>Pandémies</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Tests de criblage à haut débit</term>
<term>Tests de neutralisation</term>
<term>Vaccination</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Antibodies, Neutralizing</term>
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Antibodies, Neutralizing</term>
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Antibodies, Monoclonal</term>
<term>Antibodies, Neutralizing</term>
<term>Antibodies, Viral</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>China</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Anticorps monoclonaux</term>
<term>Anticorps neutralisants</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Herpesvirus 4, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Herpèsvirus humain de type 4</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Grippe humaine</term>
<term>Herpèsvirus humain de type 4</term>
<term>Lymphocytes B</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>B-Lymphocytes</term>
<term>Herpesvirus 4, Human</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Anticorps monoclonaux</term>
<term>Anticorps neutralisants</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>B-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Lymphocytes B</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term>
<term>Anticorps monoclonaux</term>
<term>Anticorps neutralisants</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Lymphocytes B</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>B-Lymphocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Chine</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Hemagglutination Inhibition Tests</term>
<term>High-Throughput Screening Assays</term>
<term>Humans</term>
<term>Immunologic Memory</term>
<term>Neutralization Tests</term>
<term>Pandemics</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Grippe humaine</term>
<term>Humains</term>
<term>Mémoire immunologique</term>
<term>Pandémies</term>
<term>Tests d'inhibition de l'hémagglutination</term>
<term>Tests de criblage à haut débit</term>
<term>Tests de neutralisation</term>
<term>Vaccination</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>The 2009 H1N1 influenza pandemic demonstrated the significance of a global health threat to human beings. Although pandemic H1N1 vaccines have been rapidly developed, passive serotherapy may offer superior immediate protection against infections in children, the elderly and immune-compromised patients during an influenza pandemic. Here, we applied a novel strategy based on Epstein–Barr virus (EBV)-immortalized peripheral blood memory B cells to screen high viral neutralizing monoclonal antibodies (MAbs) from individuals vaccinated with the 2009 pandemic H1N1 vaccine PANFLU.1. Through a massive screen of 13 090 immortalized memory B-cell clones from three selected vaccinees, seven MAbs were identified with both high viral neutralizing capacities and hemagglutination inhibition (HAI) activities against the 2009 pandemic H1N1 viruses. These MAbs may have important clinical implications for passive serotherapy treatments of infected patients with severe respiratory syndrome, especially children, the elderly and immunodeficient individuals. Our successful strategy for generating high-affinity MAbs from EBV-immortalized peripheral blood memory B cells may also be applicable to other infectious or autoimmune diseases.</p>
</div>
</front>
</TEI>
<affiliations><list></list>
<tree><noCountry><name sortKey="Ba, Denian" sort="Ba, Denian" uniqKey="Ba D" first="Denian" last="Ba">Denian Ba</name>
<name sortKey="Cui, Lianxian" sort="Cui, Lianxian" uniqKey="Cui L" first="Lianxian" last="Cui">Lianxian Cui</name>
<name sortKey="He, Wei" sort="He, Wei" uniqKey="He W" first="Wei" last="He">Wei He</name>
<name sortKey="Hua, Fang" sort="Hua, Fang" uniqKey="Hua F" first="Fang" last="Hua">Fang Hua</name>
<name sortKey="Ji, Xu" sort="Ji, Xu" uniqKey="Ji X" first="Xu" last="Ji">Xu Ji</name>
<name sortKey="Lu, Yanlai" sort="Lu, Yanlai" uniqKey="Lu Y" first="Yanlai" last="Lu">Yanlai Lu</name>
<name sortKey="Ma, Chi" sort="Ma, Chi" uniqKey="Ma C" first="Chi" last="Ma">Chi Ma</name>
<name sortKey="Pang, Yongsheng" sort="Pang, Yongsheng" uniqKey="Pang Y" first="Yongsheng" last="Pang">Yongsheng Pang</name>
<name sortKey="Wang, Hao" sort="Wang, Hao" uniqKey="Wang H" first="Hao" last="Wang">Hao Wang</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001345 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001345 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:4003197 |texte= Generation of human neutralizing monoclonal antibodies against the 2009 pandemic H1N1 virus from peripheral blood memory B lymphocytes }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:23912783" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a PandemieGrippaleV1
This area was generated with Dilib version V0.6.34. |